Search research articles
Contact Us
Filters
Showing results (41-50 of 91) with videos related to
Page
of 10
Sort By:
Recenti Progressi in Medicina
|
June 5, 1998
[Leptin: adipocyte hormone]
L Castagna, T De Gregorio, A Allegra, et al.
Oncogene
|
June 13, 2000
Altered natural killer cell differentiation in CD34+ progenitors from chronic myeloid leukemia patients
G Carayol, J Giron-Michel, B Azzarone, et al.
Bone Marrow Transplantation
|
December 26, 2001
Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma
M Magagnoli, B Sarina, M Balzarotti, et al.
British Journal of Haematology
|
October 29, 1998
Successful donor lymphocyte infusion (DLI) in a patient with myelodysplastic syndrome (MDS) after failure of T-cell-depleted bone marrow transplantation (TD-BMT)
L Castagna, A El Weshi, J H Bourhis, et al.
Archives of Gerontology and Geriatrics
|
January 1, 1996
Relationship between serum erythropoietin levels and rT3, T4 concentrations in elderly patients with non-thyroidal illnesses
F Corica, A Allegra, M Buemi, et al.
Vox Sanguinis
|
February 27, 2016
Bone marrow donor-related variables associated with harvest outcome in HLA-haploidentical transplantation with postinfusion cyclophosphamide
A Rimondo, S Bramanti, R Crocchiolo, et al.
Bone Marrow Transplantation
|
October 2, 2007
IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients
M Magagnoli, M Spina, M Balzarotti, et al.
Experimental Hematology
|
June 28, 2011
Prior rituximab administration is associated with reduced rate of acute GVHD after in vivo T-cell depleted transplantation in lymphoma patients
R Crocchiolo, L Castagna, J El-Cheikh, et al.
Bone Marrow Transplantation
|
October 6, 2010
Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT
L Castagna, S Fürst, N Marchetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 17, 2009
Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support
L Castagna, S Bramanti, A Levis, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 91) with videos related to
Sort By:
Page
of 10
Recenti Progressi in Medicina
|
June 5, 1998
[Leptin: adipocyte hormone]
L Castagna, T De Gregorio, A Allegra, et al.
Oncogene
|
June 13, 2000
Altered natural killer cell differentiation in CD34+ progenitors from chronic myeloid leukemia patients
G Carayol, J Giron-Michel, B Azzarone, et al.
Bone Marrow Transplantation
|
December 26, 2001
Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma
M Magagnoli, B Sarina, M Balzarotti, et al.
British Journal of Haematology
|
October 29, 1998
Successful donor lymphocyte infusion (DLI) in a patient with myelodysplastic syndrome (MDS) after failure of T-cell-depleted bone marrow transplantation (TD-BMT)
L Castagna, A El Weshi, J H Bourhis, et al.
Archives of Gerontology and Geriatrics
|
January 1, 1996
Relationship between serum erythropoietin levels and rT3, T4 concentrations in elderly patients with non-thyroidal illnesses
F Corica, A Allegra, M Buemi, et al.
Vox Sanguinis
|
February 27, 2016
Bone marrow donor-related variables associated with harvest outcome in HLA-haploidentical transplantation with postinfusion cyclophosphamide
A Rimondo, S Bramanti, R Crocchiolo, et al.
Bone Marrow Transplantation
|
October 2, 2007
IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients
M Magagnoli, M Spina, M Balzarotti, et al.
Experimental Hematology
|
June 28, 2011
Prior rituximab administration is associated with reduced rate of acute GVHD after in vivo T-cell depleted transplantation in lymphoma patients
R Crocchiolo, L Castagna, J El-Cheikh, et al.
Bone Marrow Transplantation
|
October 6, 2010
Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT
L Castagna, S Fürst, N Marchetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 17, 2009
Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support
L Castagna, S Bramanti, A Levis, et al.
Page
of 10